Related Experiment Video
Updated: Jun 12, 2026

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
Hereditary hamartomatous polyposis syndromes: understanding the disease risks as children reach adulthood
1Dr. Manfredi serves as Instructor in Pediatrics at Harvard Medical School and Associate Director of Endoscopy at Children's Hospital Boston in Boston, Massachusetts.
Insights
Hamartomatous polyposis syndromes are rare genetic disorders with malignant potential. Early detection and surveillance are crucial for managing colorectal and extracolonic cancer risks.
Area of Science:
- Gastroenterology and Genetics
Background:
- Hamartomatous polyposis syndromes are rare, autosomal dominant inherited disorders.
- These syndromes account for less than 1% of hereditary colorectal cancers.
- While hamartomatous polyps are benign, the syndromes carry risks for colorectal and extracolonic cancers.
Purpose of the Study:
- To provide a critical review of key hamartomatous polyposis syndromes.
- To cover clinical presentation, pathology, genetics, and surveillance guidelines.
- To emphasize the importance of early detection and risk management.
Main Methods:
- Literature review and critical analysis of existing data.
- Focus on juvenile polyposis syndrome, PTEN hamartoma tumor syndrome, and Peutz-Jeghers syndrome.
- Synthesis of information on clinical, pathological, genetic, and screening aspects.
Main Results:
- Detailed overview of the clinical features and pathology of the discussed syndromes.
- Summary of the genetic underpinnings of each syndrome.
- Established screening and surveillance recommendations for minimizing cancer risk.
Conclusions:
- Hamartomatous polyposis syndromes require vigilant monitoring due to cancer predisposition.
- Understanding the specific syndromes aids in tailored screening and surveillance strategies.
- Proactive management is essential for improving patient outcomes and reducing morbidity and mortality.
Abstract:
Hamartomatous polyposis syndromes are a rare group of hereditary autosomal dominant disorders that comprise less than 1% of all hereditary colorectal cancers. Hamartomatous polyps, in and of themselves, are benign entities; however, these hamartomatous polyposis syndromes have a malignant potential for the development of colorectal cancer as well as extracolonic cancers. Early detection and proper surveillance are vital to minimizing the risk of carcinoma. This article provides a critical review of the clinical presentation, pathology, genetics, and screening and surveillance guidelines of juvenile polyposis syndrome, PTEN hamartoma tumor syndrome, and Peutz-Jeghers syndrome.
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Cancers Originate from Somatic Mutations in a Single Cell
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
